BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

Ann: FOURTH SITE IN HEPATITIS C CLINICAL TRIAL, page-13

  1. inv2013
    1,011 Posts.
    lightbulb Created with Sketch. 84
    clock Created with Sketch.
    16/09/15
    15:21
    Post #: 16003677
    Surely a time line of the trial is allowed without any commentary on individual patients or lab results? Just a simple horizontal bar graph that shows milestones that have been passed. At least then we would know our trial has a heartbeat.
    BLT Price at posting: 49.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.